Literature DB >> 10490879

Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3.

J S Choi1, S J Hahn, D J Rhie, S H Yoon, Y H Jo, M S Kim.   

Abstract

The effects of fluoxetine (Prozac), a widely used antidepressant drug, on Kv1.3 stably expressed in Chinese hamster ovary cells were examined using the whole-cell and excised inside-out configurations of the patch-clamp technique. In whole-cell recordings, fluoxetine accelerated the decay rate of inactivation of Kv1.3 and thus decreased the current amplitude at the end of the pulse in a concentration-dependent manner with an IC(50) value of 5.9 microM. The inhibition displayed a weak voltage dependence, increasing at more positive potentials. Neither the activation nor the steady-state inactivation curve was affected by fluoxetine. In addition, fluoxetine reduced the tail current amplitude and slowed the deactivation of the tail current, resulting in a crossover phenomenon. When applied to the internal side of the membrane in inside-out recordings, the inhibition by fluoxetine was much faster and more potent with an IC(50) value of 1.7 microM compared with whole-cell recordings. Norfluoxetine, the major metabolite of fluoxetine, also inhibited Kv1.3 in a concentration-dependent manner (IC(50) = 1.4 microM) in whole-cell recordings. To check whether the fluoxetine-induced inhibition demonstrated in cloned Kv1.3 could also be observed in native T lymphocytes, the effects of fluoxetine were investigated on human T lymphocytes. Fluoxetine also inhibited outward K(+) current in human T lymphocytes. Our results indicate that fluoxetine produced a concentration- and voltage-dependent inhibition of Kv1.3 that can be interpreted as an open channel block and that a binding site for fluoxetine is more accessible from the intracellular side.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490879

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  27 in total

1.  The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity.

Authors:  Jianchao Xu; Peili Wang; Yanyan Li; Guoyong Li; Leonard K Kaczmarek; Yanling Wu; Pandelakis A Koni; Richard A Flavell; Gary V Desir
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

2.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

3.  Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone.

Authors:  Hye Sook Ahn; Sung Eun Kim; Hyun-Jong Jang; Myung-Jun Kim; Duck-Joo Rhie; Shin-Hee Yoon; Yang-Hyeok Jo; Myung-Suk Kim; Ki-Wug Sung; Seong Yun Kim; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11-21       Impact factor: 3.000

4.  Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells.

Authors:  Imju Jeong; Shin Hee Yoon; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-04-27       Impact factor: 3.000

5.  Selective serotonin reuptake inhibitors facilitate ANO6 (TMEM16F) current activation and phosphatidylserine exposure.

Authors:  Hyun Jong Kim; Ikhyun Jun; Jae Seok Yoon; Jinsei Jung; Yung Kyu Kim; Woo Kyung Kim; Byung Joo Kim; Jaewoo Song; Sung Joon Kim; Joo Hyun Nam; Min Goo Lee
Journal:  Pflugers Arch       Date:  2015-01-30       Impact factor: 3.657

6.  Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).

Authors:  Toru Kobayashi; Kazuo Washiyama; Kazutaka Ikeda
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

7.  Interaction of paroxetine with mitochondrial proteins mediates neuroprotection.

Authors:  Joseph P Steiner; Muznabanu Bachani; Brett Wolfson-Stofko; Myoung-Hwa Lee; Tongguang Wang; Tonguang Wang; Guanhan Li; Wenxue Li; David Strayer; Norman J Haughey; Avindra Nath
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

8.  Effects of norfluoxetine on the action potential and transmembrane ion currents in canine ventricular cardiomyocytes.

Authors:  János Magyar; Norbert Szentandrássy; Tamás Bányász; Valéria Kecskeméti; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-08-26       Impact factor: 3.000

Review 9.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

10.  Inhibition of Kv4.3 potassium channels by trazodone.

Authors:  Yun Ju Chae; Jin-Sung Choi; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-25       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.